News - Appointments

4D Pharma Plc, which is developing live biotherapeutic products for cancer, has appointed John Beck as chief financial officer and a member of the management team. Live biotherapeutics are a class of drug derived from the microbiome.

Jon Kratochvil, an experienced scientist and lawyer, has joined ERS Genomics Ltd as head of business development and licensing for North America. ERS manages intellectual property for the Crispr-Cas9 gene editing technology co-owned by Emmanuelle Charpentier.

Microbiotica Ltd has made two appointments to its management team.

The biotech and medtech entrepreneur Philippe Dro has joined Scenic Biotech BV of the Netherlands as independent chairman of the board of directors.

NOXXON Pharma NV has appointed Jose Saro as chair of its newly formed scientific advisory board which will provide strategic advice on its programmes for cancer.

The British cancer diagnostics company, Biofidelity Ltd, has named Wendy Levin as chief medical officer, based in the US.

Gerard Short has joined VarmX BV of the Netherlands as chief medical officer.

The Spanish pharma company Accure Therapeutics has announced the appointment of Rossella Medori as its chief medical officer.

Oxurion NV of Belgium has appointed Alan Stitt as chief scientific officer to help it develop ophthalmic therapies, with a focus on diabetic macular oedema.

T-knife GmbH, which is developing adoptive T cell therapies, has appointed Thomas Soloway as chief executive, and Camille Landis as chief business officer and chief financial officer, ahead of its transition from a discovery to a clinical-stage company.